Document Detail

The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy).
MedLine Citation:
PMID:  8862939     Owner:  NLM     Status:  MEDLINE    
Calcium antagonists are among the drugs most often prescribed in the treatment of cardiovascular diseases. Among the 2000 preparations most often prescribed in Germany in 1994, there were 48 calcium antagonists which presented a prescription rate of 1268 million defined daily doses. Calcium antagonists of the nifedipine type are by far the most often prescribed preparations of this group. They are targeted mainly against hypertension and coronary heart disease, with post-infarction angina pectoris also featuring among their indications. Recent publications have, in consideration of indications on possible risks associated with nifedipine medication, fanned discussions on the pros and cons of nifedipine medication and thus the value of calcium antagonists in treating hypertension and CHD as well as post-infarction patients. The purpose of this report is to analyze the current situation and to draw conclusions for the practical use of calcium antagonists.
J Schulz; J Schmidt; W Rück
Related Documents :
8022719 - Unstable angina. pharmaceutical versus invasive therapy.
19416019 - Improved myocardial perfusion in stable angina pectoris by oral lumbrokinase: a pilot s...
8059719 - Tissue-type plasminogen activator and plasminogen activator inhibitor activities as pre...
9115079 - Management of unstable angina: the role of noninvasive risk stratification.
3500629 - Beneficial effect of nitrates on myocardial glucose utilization in unstable angina pect...
1286469 - Reduced left ventricular diastolic asynchrony after captopril in single vessel coronary...
24029219 - Very small cerebellar infarcts: integration of recent insights into a functional topogr...
3694529 - Possible mechanism by which coenzyme q10 improves reoxygenation-induced recovery of car...
1889159 - Revascularization of the lower extremity with omentum.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current medical research and opinion     Volume:  13     ISSN:  0300-7995     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  1996  
Date Detail:
Created Date:  1997-01-15     Completed Date:  1997-01-15     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  397-408     Citation Subset:  IM    
Arztlicher Leiter Klinikum Buch, Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Calcium Channel Blockers / therapeutic use*
Coronary Disease / drug therapy*
Germany / epidemiology
Hypertension / drug therapy*,  epidemiology,  mortality
Middle Aged
Myocardial Infarction / drug therapy*,  mortality,  prevention & control
Nifedipine / therapeutic use*
Risk Factors
Reg. No./Substance:
0/Calcium Channel Blockers; 21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray--non-sedating in children.
Next Document:  Double-blind parallel study of a combination of chlorthalidone 50 mg and triamterene 50 mg in patien...